At Locanabio, we are developing a new class of genetic medicines that has the potential to significantly improve the lives of patients with devastating genetic diseases by correcting the message of disease-causing RNA. Our proprietary platform uses gene therapy to deliver RNA-binding systems, including snRNA, Cas13d and PUF, that can be engineered to selectively manipulate disease-causing RNA by multiple mechanisms. Our systems are designed to provide a durable therapy with a single administration without altering a cell’s DNA. Locanabio’s platform has applications across a range of tissues and diseases, and we are currently advancing programs in rare genetic neuromuscular and neurodegenerative diseases.
With world leadership in RNA biology and RNA-mediated disease and a top tier Board of Directors and panel of Scientific Advisors, we are poised to develop the next generation of genomic medicines for functional correction of disease.
Company Details
- Employees
- 10
- Founded
- 2016
- Address
- San Diego, California 92121, Us
- Phone
- 858.285.4000
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- locanabio.com
- HQ
- San Diego, California
Locanabio, Inc. Questions
Locanabio, Inc.'s helpline number is 858.285.4000
Locanabio, Inc.'s website is locanabio.com
Locanabio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/locanabio
Locanabio, Inc. has
10 employees.
View email and phone details for 10
employees at Locanabio, Inc..
Locanabio, Inc.'s industry is
Biotechnology Research
Locanabio, Inc.'s top competitors are
Eclipsebio,
Avidity Biosciences, Inc.,
Sanford Laboratories For Innovative Medicines,
Anaptysbio,
Kumquat Biosciences Inc.,
Lexeo Therapeutics,
Trotana, Inc.,
Tacit Therapeutics,
Cirsium Biosciences,
Rapport Therapeutics.
Locanabio, Inc.'s support email address is info@locanabio.com
Locanabio, Inc.'s categories are Biotechnology Research
Locanabio, Inc.'s founding year is 2016
